In summary, PLK4 overexpression is closely related to the poor prognosis of BC patients, and PLK4 suppression induces cell cycle arrest at G1 phase and inhibits BC cell proliferation via the p38/p53/p21 pathway. Here, TP53 is linked to breast cancer.